세계의 분말 흡수성 지혈제 시장 보고서(2025년)
Powder Absorbable Hemostat Global Market Report 2025
상품코드 : 1811007
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 분말 흡수성 지혈제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 연평균 성장률(CAGR) 7.2%로 확대되어 32억 7,000만 달러로 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 노인 확대, 수술 합병증 최소화 및 수술 시간 단축에 대한 주력 강화, 외래 환자와 외래 수술 증가, 신흥국 시장에서 건강 관리 인프라 개척, 생체 흡수성 제제 및 식물 유래 제형에 대한 투자 증가와 관련이 있습니다. 이 기간의 주요 동향으로는 생물제제나 식물 유래 지혈제로의 이행, 로봇 수술이나 복강경 수술에서 지혈 파우더의 채용, 병원 이외 현장이나 구급 환경에서 폭넓은 사용, 보존성이나 실온에서의 안정성 향상에 대한 대처, 전략적 파트너십의 형성이나 인수 등을 들 수 있습니다.

수술 건수 증가가 향후 몇 년간의 분말 흡수성 지혈제 시장의 확대를 견인할 것으로 예측됩니다. 수술은 부상과 질병의 치료, 신체 기능 향상을 목적으로, 손을 사용하거나 기구를 사용하는 의료 절차입니다. 외과 수술 증가는 만성 질환 유병률 상승에 의한 것이 크고, 효과적인 관리를 위해 수술이 필요하게 되는 경우가 많습니다. 이러한 수술의 급증은 효과적인 지혈 솔루션 수요를 높이고 분말 흡수성 지혈제의 사용을 증가시키고 있습니다. 이러한 지혈제는 즉각적이고 정확한 출혈 통제를 제공하기 때문에 섬세한 수술과 저침습 수술에 특히 유용하며 환자의 예후 개선으로 이어집니다. 예를 들어 영국에 본사를 둔 외과 단체 British Association of Aesthetic Plastic Surgeons에 따르면 영국은 2022년에 3만 1,057건의 미용 성형 수술을 실시하여 전년 대비 102%의 대폭 증가를 보였습니다. 그 결과, 수술 건수 증가가 분말 흡수성 지혈제 시장의 성장에 박차를 가하고 있습니다.

분말 흡수성 지혈제 시장의 주요 기업은 식물 유래 다당류 흡수성 지혈 분말과 같은 고급 제품의 개발에 주력하여 혈액 응고 효과를 향상시키고 수술 중 안전성을 높입니다. 이러한 유형의 지혈제 분말은 정제된 천연 전분에서 유래하며 혈액을 신속하게 흡수하여 혈전 형성을 시작하여 작동합니다. 완전히 생체 흡수성이므로 사용 후 제거 할 필요가 없습니다. 예를 들어, 2023년 7월 미국의 건강 관리 회사인 Baxter International Inc.는 전분 기반 수동 흡수성 지혈 파우더인 PERCLOT을 미국에서 출시했습니다. 응고계에 이상이 없는 환자용으로 설계된 PERCLOT는 수분을 신속하게 흡수하여 겔화한 점착성 매트릭스를 형성하여 기계적 장벽으로서 기능함으로써 혈소판, 적혈구, 응고 단백질의 축적을 촉진하고 경도의 수술 출혈을 억제합니다. 이 제품은 수혈과 합병증의 감소에 기여하고 건강 관리의 전체 비용을 줄임으로써 Baxter의 지혈제 제품에 참여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

An absorbable powder hemostat is a sterile, bioresorbable material designed to control bleeding during surgical procedures. Made from polysaccharides derived from plants or animals, it quickly absorbs blood and facilitates clot formation. Its powdered form enables easy application to uneven or hard-to-reach areas in surgery. The main purpose of this product is to achieve rapid hemostasis and reduce the risks associated with bleeding during surgery.

The primary categories of absorbable powder hemostats include collagen-based, gelatin-based, cellulose-based, and combination types. Collagen-based powders, sourced from bovine or porcine tissues, help accelerate clotting by activating platelets and are commonly used for effective bleeding control in surgeries. These hemostats come in various forms, including powders, ready-to-use mixes, pre-mixed, and custom formulations, and are distributed through multiple channels such as direct sales, distributors, online platforms, and pharmacies. They are applied in diverse medical fields like surgical procedures, trauma care, orthopedic operations, and cardiovascular surgeries, and are utilized by a range of end-users including hospitals, ambulatory surgical centers, specialty clinics, and outpatient surgery facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The powder absorbable hemostats market research report is one of a series of new reports from The Business Research Company that provides powder absorbable hemostats market statistics, including the powder absorbable hemostats industry global market size, regional shares, competitors with the powder absorbable hemostats market share, detailed powder absorbable hemostats market segments, market trends, opportunities, and any further data you may need to thrive in the powder absorbable hemostats industry. This powder absorbable hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The powder absorbable hemostat market size has grown strongly in recent years. It will grow from $2.30 billion in 2024 to $2.48 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period was driven by an increase in surgical procedures, expansion of minimally invasive surgeries, heightened awareness of managing surgical bleeding, greater adoption in military and emergency medicine, and a rise in FDA approvals and new product introductions.

The powder absorbable hemostat market size is expected to see strong growth in the next few years. It will grow to $3.27 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth expected in the forecast period can be linked to the expanding geriatric population, a stronger focus on minimizing surgical complications and reducing procedure times, an increase in outpatient and ambulatory surgeries, development of healthcare infrastructure in emerging markets, and rising investments in bioresorbable and plant-based formulations. Key trends during this period include a move toward biologically sourced and plant-based hemostatic agents, the incorporation of hemostatic powders in robotic and laparoscopic surgeries, broader use beyond hospitals into field and emergency environments, efforts to enhance shelf life and stability at room temperature, and the formation of strategic partnerships and acquisitions.

The growing number of surgeries is expected to drive the expansion of the powder absorbable hemostat market in the coming years. Surgeries involve hands-on or instrument-based medical procedures aimed at treating injuries, illnesses, or enhancing physical function. The increase in surgical procedures is largely due to the rising prevalence of chronic diseases, which often require surgery for effective management. This surge in surgeries boosts the demand for effective bleeding control solutions, thereby increasing the use of powder absorbable hemostats. These hemostats offer fast-acting and precise bleeding control, which is particularly valuable in delicate or minimally invasive surgeries, leading to better patient outcomes. For example, according to the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, 31,057 cosmetic surgeries were performed in the UK in 2022, reflecting a significant 102% increase compared to the previous year. Consequently, the rising number of surgeries is fueling the growth of the powder absorbable hemostat market.

Key players in the powder absorbable hemostat market are focusing on creating advanced products, such as plant-based polysaccharide absorbable hemostat powders, to improve clotting effectiveness and enhance safety during surgeries. This type of hemostatic powder is derived from purified natural starch and works by rapidly absorbing blood to initiate clot formation. It is fully bioresorbable, eliminating the need for removal after use. For instance, in July 2023, Baxter International Inc., a US-based healthcare company, launched PERCLOT, a starch-based passive absorbable hemostatic powder, in the United States. Designed for patients with intact coagulation systems, PERCLOT controls mild surgical bleeding by quickly absorbing water to form a gelled adhesive matrix that acts as a mechanical barrier, promoting the buildup of platelets, red blood cells, and coagulation proteins. This product adds to Baxter's hemostat offerings by helping reduce blood transfusions and complications, while also lowering overall healthcare costs.

In April 2025, Olympus Canada Inc., a Canadian medical technology provider, formed a partnership with EndoClot Plus, Inc. to enhance gastrointestinal (GI) care through advanced endoscopic solutions. This collaboration aims to expand Olympus' GI product line by delivering cutting-edge hemostatic technologies that improve clinical outcomes in endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) procedures throughout Canada. EndoClot Plus, Inc. is a US-based manufacturer specializing in powder absorbable hemostat systems.

Major players in the powder absorbable hemostat market are Johnson & Johnson, Becton, Dickinson and Company, Baxter International, Integra LifeSciences Corporation, CryoLife Inc., Hangzhou Singclean Medical Products Co. Ltd, Star Alliance, Gelita Medical GmbH, Algan Grup SaglIk Hizmetleri, Ferrosan Medical Devices, Hemostasis LLC, Vascular Solutions Inc., CuraMedical B.V., BioCer Entwicklungs-GmbH, Medcura Inc., Starch Medical Inc., Aegis Lifesciences, Turkish Healthcare, George & George MediSurg Ltd, and Hemostat Medical GmbH.

North America was the largest region in the powder absorbable hemostat market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in powder absorbable hemostat report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the powder absorbable hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The powder absorbable hemostat market consists of sales of chitosan-based hemostats, kaolin-based hemostats, and oxidized regenerated cellulose (ORC) powders. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Powder Absorbable Hemostat Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on powder absorbable hemostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for powder absorbable hemostat ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The powder absorbable hemostat market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Powder Absorbable Hemostat Market Characteristics

3. Powder Absorbable Hemostat Market Trends And Strategies

4. Powder Absorbable Hemostat Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Powder Absorbable Hemostat Growth Analysis And Strategic Analysis Framework

6. Powder Absorbable Hemostat Market Segmentation

7. Powder Absorbable Hemostat Market Regional And Country Analysis

8. Asia-Pacific Powder Absorbable Hemostat Market

9. China Powder Absorbable Hemostat Market

10. India Powder Absorbable Hemostat Market

11. Japan Powder Absorbable Hemostat Market

12. Australia Powder Absorbable Hemostat Market

13. Indonesia Powder Absorbable Hemostat Market

14. South Korea Powder Absorbable Hemostat Market

15. Western Europe Powder Absorbable Hemostat Market

16. UK Powder Absorbable Hemostat Market

17. Germany Powder Absorbable Hemostat Market

18. France Powder Absorbable Hemostat Market

19. Italy Powder Absorbable Hemostat Market

20. Spain Powder Absorbable Hemostat Market

21. Eastern Europe Powder Absorbable Hemostat Market

22. Russia Powder Absorbable Hemostat Market

23. North America Powder Absorbable Hemostat Market

24. USA Powder Absorbable Hemostat Market

25. Canada Powder Absorbable Hemostat Market

26. South America Powder Absorbable Hemostat Market

27. Brazil Powder Absorbable Hemostat Market

28. Middle East Powder Absorbable Hemostat Market

29. Africa Powder Absorbable Hemostat Market

30. Powder Absorbable Hemostat Market Competitive Landscape And Company Profiles

31. Powder Absorbable Hemostat Market Other Major And Innovative Companies

32. Global Powder Absorbable Hemostat Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Powder Absorbable Hemostat Market

34. Recent Developments In The Powder Absorbable Hemostat Market

35. Powder Absorbable Hemostat Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기